Gender-specific remodeling in atrial fibrillation?

Thoracic and Cardiovascular Surgeon

Volumn 61, Issue 1, 2013, Pages 66-73

  Pfannmüller, Bettina ^a   Boldt, Andreas ^a   Reutemann, Anja ^a   Duerrschmidt, Nicole ^a   Krabbes Graube, Silke ^a   Mohr, Friedrich Wilhelm ^a   Dhein, Stefan ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

arrhythmia therapy; cardiac; histology; myocardial remodeling

Indexed keywords

AMYLOID; COLLAGEN TYPE 1; CONNEXIN 40; CONNEXIN 43;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENDER; HEART ATRIUM FIBRILLATION; HEART SURGERY; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINUS RHYTHM; UPREGULATION;

AGED; AMYLOID; ATRIAL FIBRILLATION; BLOTTING, WESTERN; CASE-CONTROL STUDIES; COLLAGEN TYPE I; CONNEXIN 43; CONNEXINS; FEMALE; GAP JUNCTIONS; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEX FACTORS; STAINING AND LABELING; UP-REGULATION;

EID: 84873081492     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0032-1332795     Document Type: Article

References (37)

1. Benjamin E. J., Wolf P. A., D'Agostino R. B., Silbershatz H., Kannel W. B., Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation: 1998; 98 10 946 952 (Pubitemid 28446646)
2. Ho K. K., Pinsky J. L., Kannel W. B., Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol: 1993; 22 4 (Suppl A): 6A 13A (Pubitemid 23285789)
3. Feinberg W. M., Blackshear J. L., Laupacis A., Kronmal R., Hart R. G. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med: 1995; 155 5 469 473
4. Nattel S. New ideas about atrial fibrillation 50 years on. Nature: 2002; 415 6868 219 226 (Pubitemid 34059528)
5. Brundel B. JJM, Henning R. H., Kampinga H. H., Van Gelder I. C., Crijns H. JGM. Molecular mechanisms of remodeling in human atrial fibrillation. Cardiovasc Res: 2002; 54 2 315 324 (Pubitemid 34327911)
6. Wetzel U., Boldt A., Lauschke J., et al. Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies. Heart: 2005; 91 2 166 170
7. Dhein S. Role of connexins in atrial fibrillation. Adv Cardiol: 2006; 42 161 174 (Pubitemid 43805863)
8. Dhein S., Rothe S., Busch A., et al. Effects of metoprolol therapy on cardiac gap junction remodelling and conduction in human chronic atrial fibrillation. Br J Pharmacol: 2011; 164 2b 607 616
9. Boldt A., Wetzel U., Lauschke J., et al. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart: 2004; 90 4 400 405 (Pubitemid 38406914)
10. Röcken C., Peters B., Juenemann G., et al. Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation. Circulation: 2002; 106 16 2091 2097 (Pubitemid 35192815)
11. Polontchouk L., Haefliger J-A, Ebelt B., et al. Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol: 2001; 38 3 883 891 (Pubitemid 32835768)
12. Kostin S., Klein G., Szalay Z., Hein S., Bauer E. P., Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res: 2002; 54 2 361 379 (Pubitemid 34327915)
13. Yu W., Dahl G., Werner R. The connexin43 gene is responsive to oestrogen. Proc Biol Sci: 1994; 255 1343 125 132 (Pubitemid 24065825)
14. Grohé C., Kahlert S., Löbbert K., et al. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett: 1997; 416 1 107 112 (Pubitemid 27470812)
15. Rosenkranz-Weiss P., Tomek R. J., Mathew J., Eghbali M. Gender-specific differences in expression of mRNAs for functional and structural proteins in rat ventricular myocardium. J Mol Cell Cardiol: 1994; 26 2 261 270 (Pubitemid 24102814)
16. Puchtler H., Waldrop F. S., Meloan S. N. A review of light, polarization and fluorescence microscopic methods for amyloid. Appl Pathol: 1985; 3 1-2 5 17 (Pubitemid 17173758)
17. Linhares V. L., Almeida N. A., Menezes D. C., et al. Transcriptional regulation of the murine Connexin40 promoter by cardiac factors Nkx2-5, GATA4 and Tbx5. Cardiovasc Res: 2004; 64 3 402 411 (Pubitemid 39505419)
18. Seul K. H., Tadros P. N., Beyer E. C. Mouse connexin40: gene structure and promoter analysis. Genomics: 1997; 46 1 120 126 (Pubitemid 27527699)
19. Teunissen B. E., van Amersfoorth S. C., Opthof T., Jongsma H. J., Bierhuizen M. F. Sp1 and Sp3 activate the rat connexin40 proximal promoter. Biochem Biophys Res Commun: 2002; 292 1 71 78 (Pubitemid 34687330)
20. Dupays L., Mazurais D., Rücker-Martin C., et al. Genomic organization and alternative transcripts of the human Connexin40 gene. Gene: 2003; 305 1 79 90 (Pubitemid 36197868)
21. Dhein S., Duerrschmidt N., Scholl A., et al. A new role for extracellular Ca2+ in gap-junction remodeling: studies in humans and rats. Naunyn Schmiedebergs Arch Pharmacol: 2008; 377 2 125 138
22. Yan H., Chen J. Z., Zhu J. H., et al. [Expression of connexin in atrium of patients with atrial fibrillation and its signal transduction pathway]. Zhonghua Yi Xue Za Zhi: 2004; 84 3 209 213
23. Li D. Q., Feng Y. B., Zhang H. Q. [The relationship between gap junctional remodeling and atrial fibrillation in patients with rheumatic heart disease]. Zhonghua Yi Xue Za Zhi: 2004; 84 5 384 386
24. Luo M. H., Li Y. S., Yang K. P. Fibrosis of collagen I and remodeling of connexin 43 in atrial myocardium of patients with atrial fibrillation. Cardiology: 2007; 107 4 248 253 (Pubitemid 46788240)
25. Huang X. D., Sandusky G. E., Zipes D. P. Heterogeneous loss of connexin43 protein in ischemic dog hearts. J Cardiovasc Electrophysiol: 1999; 10 1 79 91 (Pubitemid 29039495)
26. Kaprielian R. R., Gunning M., Dupont E., et al. Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation: 1998; 97 7 651 660 (Pubitemid 28090958)
27. Jozwiak J., Dhein S. Local effects and mechanisms of antiarrhythmic peptide AAP10 in acute regional myocardial ischemia: electrophysiological and molecular findings. Naunyn Schmiedebergs Arch Pharmacol: 2008; 378 5 459 470
28. Girmatsion Z., Biliczki P., Bonauer A., et al. Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation. Heart Rhythm: 2009; 6 12 1802 1809
29. Wang Z., Lu Y., Yang B. MicroRNAs and atrial fibrillation: new fundamentals. Cardiovasc Res: 2011; 89 4 710 721
30. Gramley F., Lorenzen J., Koellensperger E., Kettering K., Weiss C., Munzel T. Atrial fibrosis and atrial fibrillation: the role of the TGF-β1 signaling pathway. Int J Cardiol: 2010; 143 3 405 413
31. Villar A. V., Llano M., Cobo M., et al. Gender differences of echocardiographic and gene expression patterns in human pressure overload left ventricular hypertrophy. J Mol Cell Cardiol: 2009; 46 4 526 535
32. Goette A., Röcken C. Atrial amyloidosis and atrial fibrillation: a gender-dependent "arrhythmogenic substrateo"? Eur Heart J: 2004; 25 14 1185 1186 (Pubitemid 38891567)
33. Ariyarajah V., Steiner I., Hájková P., et al. The association of atrial tachyarrhythmias with isolated atrial amyloid disease: preliminary observations in autopsied heart specimens. Cardiology: 2009; 113 2 132 137
34. Steiner I., Hájková P. Patterns of isolated atrial amyloid: a study of 100 hearts on autopsy. Cardiovasc Pathol: 2006; 15 5 287 290 (Pubitemid 44345233)
35. Leone O., Boriani G., Chiappini B., et al. Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation. Eur Heart J: 2004; 25 1237 1241 (Pubitemid 38891574)
36. Volgman A. S., Manankil M. F., Mookherjee D., Trohman R. G. Women with atrial fibrillation: Greater risk, less attention. Gend Med: 2009; 6 3 419 432
37. Friberg J., Scharling H., Gadsboll N., Jensen G. B. Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study). Am J Cardiol: 2003; 92 12 1419 1423 (Pubitemid 37532563)